Oscar Health (OSCR) to Release Quarterly Earnings on Wednesday

Key Points

• Oscar Health will report Q1 2026 results before the market opens on May 6, with analysts expecting about $1.21 EPS and $4.9075 billion in revenue and a conference call scheduled for 8:00 AM ET.
• The company missed prior-quarter estimates (reported a $1.24 loss vs. -$0.92 expected and revenue of $2.81B vs. $3.12B), carries negative margins, and the stock has a consensus “Hold” rating with an average target of $16.78.
• CEO Mark T. Bertolini bought 1,000,000 shares at $11.92 in April—boosting his stake to ~10.87%—and insiders now own 25.11% of the company.

Oscar Health (NYSE:OSCR - Get Free Report) is anticipated to announce its Q1 2026 results before the market opens on Wednesday, May 6th. Analysts expect the company to announce earnings of $1.21 per share and revenue of $4.9075 billion for the quarter. Investors can find conference call details on the company's upcoming Q1 2026 earning report page for the latest details on the call scheduled for Wednesday, May 6, 2026 at 8:00 AM ET.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Tuesday, February 10th. The company reported ($1.24) EPS for the quarter, missing analysts' consensus estimates of ($0.92) by ($0.32). Oscar Health had a negative net margin of 3.79% and a negative return on equity of 39.35%. The company had revenue of $2.81 billion during the quarter, compared to analyst estimates of $3.12 billion. During the same quarter in the previous year, the firm earned ($0.62) earnings per share. The business's revenue was up 17.3% on a year-over-year basis. On average, analysts expect Oscar Health to post $0 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Oscar Health Stock Performance

Shares of OSCR stock opened at $18.04 on Wednesday. The company has a quick ratio of 0.96, a current ratio of 0.96 and a debt-to-equity ratio of 0.44. The business has a 50 day moving average of $13.84 and a two-hundred day moving average of $15.34. Oscar Health has a 52 week low of $10.69 and a 52 week high of $23.80. The company has a market cap of $5.37 billion, a P/E ratio of -10.37 and a beta of 1.93.

Analyst Upgrades and Downgrades

A number of equities analysts have commented on OSCR shares. Weiss Ratings restated a "sell (d)" rating on shares of Oscar Health in a research note on Tuesday, April 21st. Barclays set a $18.00 target price on Oscar Health and gave the company an "equal weight" rating in a research note on Monday, January 5th. UBS Group restated a "neutral" rating and issued a $15.00 target price on shares of Oscar Health in a research note on Wednesday, February 11th. Raymond James Financial upgraded Oscar Health from a "market perform" rating to an "outperform" rating and set a $18.00 target price for the company in a research note on Thursday, February 12th. Finally, Jefferies Financial Group upgraded Oscar Health from an "underperform" rating to a "hold" rating and lifted their target price for the company from $10.00 to $16.00 in a research note on Monday, April 20th. Two investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $16.78.

Insider Activity

In other Oscar Health news, CEO Mark T. Bertolini acquired 1,000,000 shares of Oscar Health stock in a transaction dated Monday, April 6th. The stock was acquired at an average cost of $11.92 per share, for a total transaction of $11,920,000.00. Following the completion of the transaction, the chief executive officer owned 10,196,876 shares in the company, valued at approximately $121,546,761.92. This represents a 10.87% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 25.11% of the company's stock.

Hedge Funds Weigh In On Oscar Health

Several hedge funds and other institutional investors have recently made changes to their positions in the business. T. Rowe Price Investment Management Inc. boosted its position in shares of Oscar Health by 11.0% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company's stock worth $132,461,000 after buying an additional 910,320 shares during the period. Invesco Ltd. boosted its position in shares of Oscar Health by 14.4% during the fourth quarter. Invesco Ltd. now owns 303,434 shares of the company's stock worth $4,360,000 after buying an additional 38,163 shares during the period. XTX Topco Ltd boosted its position in shares of Oscar Health by 16.0% during the fourth quarter. XTX Topco Ltd now owns 107,854 shares of the company's stock worth $1,550,000 after buying an additional 14,865 shares during the period. VARCOV Co. acquired a new position in shares of Oscar Health during the fourth quarter worth approximately $688,000. Finally, Wellington Management Group LLP boosted its position in shares of Oscar Health by 4.1% during the fourth quarter. Wellington Management Group LLP now owns 374,015 shares of the company's stock worth $5,375,000 after buying an additional 14,590 shares during the period. 75.70% of the stock is currently owned by institutional investors and hedge funds.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.